UK Launches £10 Million IDAP Pilot Program For Rapid Medical Technology Access 21 Sep, 2023: The UK Government has allocated £10 million in funding, to launch the Innovative Devices Access Pathway (IDAP) pilot program. This initiative is specifically designed to expedite the
Enlightening Session with Tadas Gudėnas, Founder and CEO of Innovative Care of Dementia Biotechnology has orchestrated a remarkable transformation within the healthcare industry, unveiling an array of awe-inspiring solutions, spanning from nutrient-fortified foods to cutting-edge therapeutic interventions to unlimited more. In a recent
DP Medical To Bring Diagnostics Technology To The UK In Collaboration With Neuranix 07 Sep, 2023: DP Medical Systems, the UK’s prominent healthcare supplier, has partnered with Italy-based healthcare diagnosis company, Neuranix to introduce a groundbreaking audiology diagnostic device to the markets
Revolutionizing Biotech: Exploring the Future of Regenerative Medicine at the London Biotechnology Show The incredible progress in healthcare technologies is truly awe-inspiring, enabling the treatment of illnesses that were once unimaginable. Let’s take an example of a body's healing process.
Innovate UK Invests In Powdered Gene Therapy For Bone Graft Augmentation 01 Sep, 2023: TherageniX, a University of Nottingham spin-off, that is at the forefront of dry powder gene therapy for bone graft augmentation, has secured a substantial £995,000 grant
Informative Session with Dr Ali. Ghanem, Scientist and R&D Consultant Advanced therapies are assimilating into the core of mainstream healthcare at an ideal pace. To gain insight into the current landscape, Muhammad Younis recently conducted an interview with Dr. Ali
England Unveils Groundbreaking 7-Minute Cancer Treatment Injection 01 Sep, 2023: The UK's state-run National Health Service (NHS) will become the global pioneer in providing a groundbreaking cancer treatment injection to hundreds of patients in England
An Informative Q&A Session with Deon Neveling, CEO and Co-founder of Biotikum Natural microbial communities are turning out to be one of the effective remedial approaches in combating diseases. In a recent Q&A dialogue with Deon Neveling, CEO and Co-founder
Innovate UK Commits £13 Million To Revolutionise Medicines Manufacturing 22 Aug, 2023: The UK’s national innovation agency, Innovate UK is injecting £13 Million into the biopharmaceutical manufacturing sector in the UK. This financial infusion is a component of
Interview with Dr Ashley Naidoo, Director of Natmed Solutions The landscape of healthcare is being reshaped by the revolutionary progress of Microbiome Therapeutics, exerting substantial influence on the industry, globally. In a recent interview, Dr Ashley Naidoo, Director of
Bioengineered Enzyme-Scissors Uncover New Pathways For Tackling Cancer Resistance 10 Aug, 2023: Scientists at Stanford University have developed a biomolecule that targets and eliminates mucins exclusively within cancer cells. This finding holds great promise for potential cancer treatments in
Insightful Session with Dr Alexander Ariel Padrón González, Medical Doctor and a specialist in Basic and Clinical Immunology Revolutionising the healthcare domain, advanced therapies have completely transformed the way we approach medical treatment. In a recent interview, Dr Alexander Ariel Padrón González, a seasoned Medical Doctor and a
Interview with Dr Amine Zorgani, Founder of Microbiome Mavericks Microbiome therapeutics represents a transformative leap in healthcare. In a recent interview, Dr Amine Zorgani delved into this pioneering field with Muhammad Younis, exploring its vast potential to enhance human
OncoNPC: Revolutionary Tool To Help Doctors Identify and Treat Cancers of Unknown Origin August 7, 2023: Researchers at the Massachusetts Institute of Technology (MIT) and the Dana-Farber Cancer Institute have developed a groundbreaking approach utilising machine learning to address the challenge of identifying
Scientists Develop New Bioink for 3D Bioprinting of Tumour Models August 7, 2023: Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a new bioink that can be used to create more accurate 3D tumour models. The bioink,